360 High-Risk Vulnerability Immunization Tool V2.0 vs VIPRE Endpoint Security Cloud: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

VIPRE Endpoint Security Cloud: Cloud-based endpoint security platform with EDR and optional MDR services. built by Vipre. Core capabilities include Zero-day and bulk malware protection, AI-based behavior analysis, DNS protection..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. VIPRE Endpoint Security Cloud differentiates with Zero-day and bulk malware protection, AI-based behavior analysis, DNS protection.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). VIPRE Endpoint Security Cloud is developed by Vipre. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and VIPRE Endpoint Security Cloud serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.